ARA-290 (Cibinetide) – Research Peptide
At New Wave Peptides, our ARA-290 is a high-purity research-grade peptide widely studied for its potential roles in inflammation modulation, tissue protection, neural recovery, and immune pathway signalling. ARA-290 (also known as Cibinetide) is a synthetic pyroglutamate peptide designed for research into pathways involving the innate repair receptor (IRR). This product is intended strictly for laboratory-based studies in controlled research environments.
Download Third Party COA: ARA-290 COA
Each batch is independently analysed by Janoshik, a globally recognised specialist in peptide testing. We verify every new batch to maintain consistency, accuracy, and transparency across all products. The batch number is printed on each vial and corresponds directly to the Certificate of Analysis (COA) for complete traceability.
- Batch Number: 19970 (10MG)
- Molecular Formula: C?H?N?O? (manufacturer-dependent, can be added if you have the exact values)
- Peptide Sequence: Pyr-Glu-Glu-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser-Leu-Leu-Gly-Lys
- Research Only: Yes
- Purity: 99%+
- Form: Lyophilised Solid
- Mixing Water Required: Yes
Usage and Storage:
ARA-290 is supplied as a lyophilised powder to ensure maximum stability and reliability during research handling. For best results, follow recommended reconstitution guidelines and store appropriately to maintain structural integrity and performance in laboratory conditions.
Peptide Mixing Notes
Allow both the peptide vial and sterile diluent to reach room temperature prior to reconstitution. This prevents condensation and temperature shock, supporting full solubility. Avoid vigorous shaking and store the reconstituted solution according to best laboratory practices to preserve peptide activity.
⚠️ Research Use Only – Important Legal Notice
Used solely for in vitro experiments and cannot be:
- Used in clinical trials involving humans
- Administered to humans as part of an experiment or investigation,
- Supplied to another party for human investigational use.
